Search details
1.
The Women's Health Initiative Randomized Trials and Clinical Practice: A Review.
JAMA
; 331(20): 1748-1760, 2024 05 28.
Article
in English
| MEDLINE | ID: mdl-38691368
2.
Randomized Trial Evaluation of the Benefits and Risks of Menopausal Hormone Therapy Among Women 50-59 Years of Age.
Am J Epidemiol
; 190(3): 365-375, 2021 02 01.
Article
in English
| MEDLINE | ID: mdl-33025002
3.
Dual-Outcome Intention-to-Treat Analyses in the Women's Health Initiative Randomized Controlled Hormone Therapy Trials.
Am J Epidemiol
; 189(9): 972-981, 2020 09 01.
Article
in English
| MEDLINE | ID: mdl-32314781
4.
Menopausal Estrogen-Alone Therapy and Health Outcomes in Women With and Without Bilateral Oophorectomy: A Randomized Trial.
Ann Intern Med
; 171(6): 406-414, 2019 09 17.
Article
in English
| MEDLINE | ID: mdl-31499528
5.
Low-Fat Dietary Pattern among Postmenopausal Women Influences Long-Term Cancer, Cardiovascular Disease, and Diabetes Outcomes.
J Nutr
; 149(9): 1565-1574, 2019 09 01.
Article
in English
| MEDLINE | ID: mdl-31175807
6.
Association of Traditional Cardiovascular Risk Factors With Venous Thromboembolism: An Individual Participant Data Meta-Analysis of Prospective Studies.
Circulation
; 135(1): 7-16, 2017 01 03.
Article
in English
| MEDLINE | ID: mdl-27831499
7.
Associations of Biomarker-Calibrated Sodium and Potassium Intakes With Cardiovascular Disease Risk Among Postmenopausal Women.
Am J Epidemiol
; 186(9): 1035-1043, 2017 Nov 01.
Article
in English
| MEDLINE | ID: mdl-28633342
8.
Theoretical Effects of Substituting Butter with Margarine on Risk of Cardiovascular Disease.
Epidemiology
; 28(1): 145-156, 2017 01.
Article
in English
| MEDLINE | ID: mdl-27648593
9.
Tissue Factor Pathway Inhibitor, Activated Protein C Resistance, and Risk of Coronary Heart Disease Due To Combined Estrogen Plus Progestin Therapy.
Arterioscler Thromb Vasc Biol
; 36(2): 418-24, 2016 Feb.
Article
in English
| MEDLINE | ID: mdl-26681757
10.
Menopausal Hormone Therapy and Long-term All-Cause and Cause-Specific Mortality: The Women's Health Initiative Randomized Trials.
JAMA
; 318(10): 927-938, 2017 09 12.
Article
in English
| MEDLINE | ID: mdl-28898378
11.
Prentice et al. Respond to "Studying Co-Occurrence of Multiple Outcomes".
Am J Epidemiol
; 189(9): 985-986, 2020 09 01.
Article
in English
| MEDLINE | ID: mdl-32314786
12.
Economic return from the Women's Health Initiative estrogen plus progestin clinical trial: a modeling study.
Ann Intern Med
; 160(9): 594-602, 2014 May 06.
Article
in English
| MEDLINE | ID: mdl-24798522
13.
Sex hormone associations with breast cancer risk and the mediation of randomized trial postmenopausal hormone therapy effects.
Breast Cancer Res
; 16(2): R30, 2014 Mar 26.
Article
in English
| MEDLINE | ID: mdl-24670297
14.
Associations of fats and carbohydrates with cardiovascular disease and mortality-PURE and simple?
Lancet
; 391(10131): 1677, 2018 04 28.
Article
in English
| MEDLINE | ID: mdl-29726336
15.
Estrogens and cardiovascular disease risk revisited: the Women's Health Initiative.
Curr Opin Lipidol
; 24(6): 493-9, 2013 Dec.
Article
in English
| MEDLINE | ID: mdl-24184944
16.
The Intersection of Cardiovascular Health and Maternal Health: Portfolio Analysis of Federal Grant Funding 2016-2021.
J Womens Health (Larchmt)
; 33(5): 565-572, 2024 May.
Article
in English
| MEDLINE | ID: mdl-38573239
17.
Comparison of the Framingham and Reynolds Risk scores for global cardiovascular risk prediction in the multiethnic Women's Health Initiative.
Circulation
; 125(14): 1748-56, S1-11, 2012 Apr 10.
Article
in English
| MEDLINE | ID: mdl-22399535
18.
Relationships of coronary heart disease with 27-hydroxycholesterol, low-density lipoprotein cholesterol, and menopausal hormone therapy.
Circulation
; 126(13): 1577-86, 2012 Sep 25.
Article
in English
| MEDLINE | ID: mdl-22932256
19.
Menopausal Estrogen Therapy and Breast Cancer Mortality-Reply.
JAMA
; 319(2): 193-194, 2018 01 09.
Article
in English
| MEDLINE | ID: mdl-29318272
20.
Menopausal hormone therapy and health outcomes during the intervention and extended poststopping phases of the Women's Health Initiative randomized trials.
JAMA
; 310(13): 1353-68, 2013 Oct 02.
Article
in English
| MEDLINE | ID: mdl-24084921